| Related Articles |
Kidney cancer: First-in-class HIF2α antagonist safe and effective.
Nat Rev Clin Oncol. 2018 Jan 16;:
Authors: Sidaway P
PMID: 29335652 [PubMed - as supplied by publisher]
from #PM All via ola Kala on Inoreader http://ift.tt/2FQ3j6X
| Related Articles |
Kidney cancer: First-in-class HIF2α antagonist safe and effective.
Nat Rev Clin Oncol. 2018 Jan 16;:
Authors: Sidaway P
PMID: 29335652 [PubMed - as supplied by publisher]
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου